198 related articles for article (PubMed ID: 25384216)
1. GP130 activation induces myeloma and collaborates with MYC.
Dechow T; Steidle S; Götze KS; Rudelius M; Behnke K; Pechloff K; Kratzat S; Bullinger L; Fend F; Soberon V; Mitova N; Li Z; Thaler M; Bauer J; Pietschmann E; Albers C; Grundler R; Schmidt-Supprian M; Ruland J; Peschel C; Duyster J; Rose-John S; Bassermann F; Keller U
J Clin Invest; 2014 Dec; 124(12):5263-74. PubMed ID: 25384216
[TBL] [Abstract][Full Text] [Related]
2. Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma.
Scherger AK; Al-Maarri M; Maurer HC; Schick M; Maurer S; Öllinger R; Gonzalez-Menendez I; Martella M; Thaler M; Pechloff K; Steiger K; Sander S; Ruland J; Rad R; Quintanilla-Martinez L; Wunderlich FT; Rose-John S; Keller U
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391340
[TBL] [Abstract][Full Text] [Related]
3. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells.
Cheung WC; Van Ness B
Leukemia; 2002 Jun; 16(6):1182-8. PubMed ID: 12040451
[TBL] [Abstract][Full Text] [Related]
4. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
5. Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice.
Ruwanpura SM; McLeod L; Miller A; Jones J; Vlahos R; Ramm G; Longano A; Bardin PG; Bozinovski S; Anderson GP; Jenkins BJ
Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(7):L627-39. PubMed ID: 22268122
[TBL] [Abstract][Full Text] [Related]
6. Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling.
Jenkins BJ; Grail D; Nheu T; Najdovska M; Wang B; Waring P; Inglese M; McLoughlin RM; Jones SA; Topley N; Baumann H; Judd LM; Giraud AS; Boussioutas A; Zhu HJ; Ernst M
Nat Med; 2005 Aug; 11(8):845-52. PubMed ID: 16041381
[TBL] [Abstract][Full Text] [Related]
7. Endogenous transmembrane protein UT2 inhibits pSTAT3 and suppresses hematological malignancy.
Lee D; Wang YH; Kalaitzidis D; Ramachandran J; Eda H; Sykes DB; Raje N; Scadden DT
J Clin Invest; 2016 Apr; 126(4):1300-10. PubMed ID: 26927669
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases.
Hausherr A; Tavares R; Schäffer M; Obermeier A; Miksch C; Mitina O; Ellwart J; Hallek M; Krause G
Oncogene; 2007 Jul; 26(34):4987-98. PubMed ID: 17310994
[TBL] [Abstract][Full Text] [Related]
9. Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
French JD; Tschumper RC; Jelinek DF
Leukemia; 2002 Jun; 16(6):1189-96. PubMed ID: 12040452
[TBL] [Abstract][Full Text] [Related]
10. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction.
Hilfiker-Kleiner D; Shukla P; Klein G; Schaefer A; Stapel B; Hoch M; Müller W; Scherr M; Theilmeier G; Ernst M; Hilfiker A; Drexler H
Circulation; 2010 Jul; 122(2):145-55. PubMed ID: 20585009
[TBL] [Abstract][Full Text] [Related]
11. FGF signaling inhibits the proliferation of human myeloma cells and reduces c-myc expression.
Firme L; Bush AB
BMC Cell Biol; 2003 Dec; 4():17. PubMed ID: 14656381
[TBL] [Abstract][Full Text] [Related]
12. Activated Rac1 requires gp130 for Stat3 activation, cell proliferation and migration.
Arulanandam R; Geletu M; Feracci H; Raptis L
Exp Cell Res; 2010 Mar; 316(5):875-86. PubMed ID: 19852956
[TBL] [Abstract][Full Text] [Related]
13. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
14. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
[TBL] [Abstract][Full Text] [Related]
15. Determinants governing the potency of STAT3 activation via the individual STAT3-recruiting motifs of gp130.
Lehmann U; Sommer U; Smyczek T; Hörtner M; Frisch W; Volkmer-Engert R; Heinrich PC; Schaper F; Haan S
Cell Signal; 2006 Jan; 18(1):40-9. PubMed ID: 15927449
[TBL] [Abstract][Full Text] [Related]
16. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
[TBL] [Abstract][Full Text] [Related]
17. Functional involvement of Daxx in gp130-mediated cell growth and survival in BaF3 cells.
Muromoto R; Kuroda M; Togi S; Sekine Y; Nanbo A; Shimoda K; Oritani K; Matsuda T
Eur J Immunol; 2010 Dec; 40(12):3570-80. PubMed ID: 21108476
[TBL] [Abstract][Full Text] [Related]
18. Differential role of gp130-dependent STAT and Ras signalling for haematopoiesis following bone-marrow transplantation.
Kroy DC; Hebing L; Sander LE; Gassler N; Erschfeld S; Sackett S; Galm O; Trautwein C; Streetz KL
PLoS One; 2012; 7(6):e39728. PubMed ID: 22745821
[TBL] [Abstract][Full Text] [Related]
19. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis.
Judd LM; Bredin K; Kalantzis A; Jenkins BJ; Ernst M; Giraud AS
Gastroenterology; 2006 Oct; 131(4):1073-85. PubMed ID: 17030178
[TBL] [Abstract][Full Text] [Related]
20. Gp130-dependent signaling in the podocyte.
Nagayama Y; Braun GS; Jakobs CM; Maruta Y; van Roeyen CR; Klinkhammer BM; Boor P; Villa L; Raffetseder U; Trautwein C; Görtz D; Müller-Newen G; Ostendorf T; Floege J
Am J Physiol Renal Physiol; 2014 Aug; 307(3):F346-55. PubMed ID: 24899055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
